Company / FCF Margin
Moderna FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-106.2%
FY2025
5-year range
-818.3% / 244.0%
FY2021-FY2025
Trend
+15.2%
vs FY2024
Sector context
#92 of 134
Health Care
What the data says
At -106.2%, Moderna's fcf margin ranks #92 of 134 in the Health Care sector. FCF Margin returned to growth in FY2025 after 2 years of decline, reaching -106.2%.
Based on SEC 10-K filings.
-106.2% in FY2025 with a 5-year CAGR of -350.2%.
Declined from -55.9% to -106.2% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -350.2pp
- 5-Year Change
- -350.2pp
- 10-Year Change
- -
Sector benchmark
#92 of 134 in Health CareTop 69% of 134This company -106.2% Sector average -637.8%
▼
+83.3% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 15.2% year-over-year.
- Currently 531.6pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -106.2% | +15.2% |
| FY2024 | -125.3% | -124.3% |
| FY2023 | -55.9% | -122.9% |
| FY2022 | 244.0% | +129.8% |
| FY2021 | -818.3% | -435.4% |
| FY2020 | 244.0% | +129.8% |
| FY2019 | -818.3% | -153.1% |
| FY2018 | -323.3% | - |
| FY2017 | - | - |
| FY2016 | 31.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026